Venous thromboembolism in pregnancy: Prophylaxis and treatment with low molecular weight heparin

Acta Obstetricia et Gynecologica Scandinavica

Volumn 89, Issue 1, 2010, Pages 15-21

  Andersen, Anita Sylvest ^a   Berthelsen, Jørgen G ^a   Bergholt, Thomas ^a  

^a HILLERØD HOSPITAL   (Denmark)

Author keywords

Adverse obstetric outcome; Low molecular weight heparin; Pregnancy; Thrombophilia; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN;

ADULT; ARTICLE; CESAREAN SECTION; FEMALE; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE LABOR; RETROSPECTIVE STUDY; STATISTICS; VENOUS THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; CESAREAN SECTION; DALTEPARIN; FEMALE; FETAL GROWTH RETARDATION; FIBRINOLYTIC AGENTS; GESTATIONAL AGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM;

EID: 74049153667     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016340903370098     Document Type: Article

References (25)

1. Lewis G (ed). Saving mothers' lives: reviewing maternal deaths to make motherhood safer - 2003-2005. Confidential Enquiry into Maternal and Child Health. The Seventh Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press, 2007.
2. Simpson EL, Lawrenson RA, Nightingale A.L., Farmer RD Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG. 2001; 108:56-60.
3. Hellgren M. Hemostasis during normal pregnancy and puer-perium. Semin Thromb Hemost. 2003; 29:125-30.
4. Brenner B. Haemostatic changes in pregnancy. Thromb Res. 2004; 114:409-14.
5. Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet. 1999; 353:1258-65.
6. James AH, Tapson VF, Goldhaber SZ Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol. 2005; 193:216-19.
7. Blanco-Molina A., Trujillo-Santos J, Criado J., Lopez L, Lecumberri R, Gutierrez R., et al Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Thromb Haemost. 2007; 97:186-90.
8. Pabinger I, Grafenhofer H, Kyrle P.A., Quehenberger P., Mannhalter C, Lechner K, et al Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood. 2002; 100:1060-2.
9. Pabinger I, Grafenhofer H, Kaider A., Kyrle PA, Quehenberger P, Mannhalter C, et al Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost. 2005; 3:949-54.
10. Bergqvist A, Bergqvist D, Lindhagen A., Matzsch T. Late symptoms after pregnancy-related deep vein thrombosis. Br J Obstet Gynaecol. 1990; 97:338-41.
11. McColl MD, Ellison J, Greer I.A., Tait RC, Walker ID Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism. Br J Haematol. 2000; 108:272-4.
12. Ziegler S, Schillinger M, Maca T.H., Minar E. Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago. Thromb Res. 2001; 101:23-33.
13. Pabinger I, Grafenhofer H, Kaider A., Ilic A, Eichinger S, Quehenberger P., et al Preeclampsia and fetal loss in women with a history of venous thromboembolism. Arterioscler Thromb Vasc Biol. 2001; 21:874-9.
14. Greer IA. The special case of venous thromboembolism in pregnancy. Haemostasis. 1998; 28(SUPPL. 3):22-34.
15. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol. 2002; 101:6-14.
16. Kupferminc MJ, Eldor A, Steinman N., Many A, Bar-Am A, Jaffa A, et al Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999; 340:9-13.
17. Kupferminc MJ, Eldor A. Inherited thrombophilia and ges-tational vascular complications. Semin Thromb Hemost. 2003; 29:185-94.
18. Kupferminc MJ, Fait G, Many A., Gordon D, Eldor A, Lessing JB Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol. 2000; 96: 45-9.
19. Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol. 2002; 99:333-41.
20. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboem-bolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005; 106:401-7.
21. Juul K, Tybjaerg-Hansen A, Steffensen R., Kofoed S, Jensen G, Nordestgaard BG Factor V Leiden: TheCopenhagenCityHeart Study and 2 meta-analyses. Blood. 2002; 100:3-10.
22. Maslovitz S, Many A, Landsberg J.A., Varon D., Lessing JB, Kupferminc MJ The safety of low molecular weight heparin therapy during labor. J Matern Fetal Neonatal Med. 2005; 17:39-43.
23. Prasertcharoensuk W, Swadpanich U, Lumbiganon P. Accuracy of the blood loss estimation in the third stage of labor. Int J Gynaecol Obstet. 2000; 71:69-70.
24. Freedman RA, Bauer KA, Neuberg D.S., Zwicker JI Timing of postpartum enoxaparin administration and severe postpartum hemorrhage. Blood Coagul Fibrinolysis. 2008; 19:55-9.
25. Kominiarek MA, Angelopoulos SM, Shapiro N.L., Studee L., Nutescu EA, Hibbard JU Low-molecular-weight heparin in pregnancy: peripartum bleeding complications. J Perinatol. 2007; 27:329-34.